Clinical Trial Update: Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial update on ranibizumab for diabetic macular edema, examining a regimen of initial treatment followed by bimonthly monitoring.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetic Retinopathy, Macular Oedema | Phase 4 | Status: COMPLETED